<SEC-DOCUMENT>0001683168-18-001713-index.html : 20180615 <SEC-HEADER>0001683168-18-001713.hdr.sgml : 20180615 <ACCEPTANCE-DATETIME>20180615172204 ACCESSION NUMBER: 0001683168-18-001713 CONFORMED SUBMISSION TYPE: 1-A PUBLIC DOCUMENT COUNT: 11 FILED AS OF DATE: 20180615 DATE AS OF CHANGE: 20180615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001729427 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822318545 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 1-A SEC ACT: 1933 Act SEC FILE NUMBER: 024-10855 FILM NUMBER: 18903070 BUSINESS ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: 1-800-946-9185 X701 MAIL ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 </SEC-HEADER> <DOCUMENT> <TYPE>1-A <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>PART II AND III <SEQUENCE>2 <FILENAME>cns_1a-poc.htm <DESCRIPTION>PRELIMINARY OFFERING STATEMENT <TEXT> Document 2 - file: cns_1a-poc.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX1A-3 HLDRS RTS <SEQUENCE>3 <FILENAME>cns_a1-ex0301.htm <DESCRIPTION>FORM OF CONVERTIBLE PROMISSORY NOTE <TEXT> Document 3 - file: cns_a1-ex0301.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX1A-3 HLDRS RTS <SEQUENCE>4 <FILENAME>cns_a1-ex0302.htm <DESCRIPTION>FORM OF COMMON STOCK PURCHASE WARRANT <TEXT> Document 4 - file: cns_a1-ex0302.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX1A-3 HLDRS RTS <SEQUENCE>5 <FILENAME>cns_a1-ex0303.htm <DESCRIPTION>FORM OF SAFE AGREEMENT <TEXT> Document 5 - file: cns_a1-ex0303.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX1A-6 MAT CTRCT <SEQUENCE>6 <FILENAME>cns_a1-ex0601.htm <DESCRIPTION>AMENDED AND RESTATED PATENT LICENSE AGREEMENT <TEXT> Document 6 - file: cns_a1-ex0601.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX1A-6 MAT CTRCT <SEQUENCE>7 <FILENAME>cns_a1-ex0602.htm <DESCRIPTION>COLLABORATION AND ASSET PURCHASE AGREEMENT <TEXT> Document 7 - file: cns_a1-ex0602.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX1A-6 MAT CTRCT <SEQUENCE>8 <FILENAME>cns_a1-ex0603.htm <DESCRIPTION>2017 STOCK PLAN <TEXT> Document 8 - file: cns_a1-ex0603.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX1A-6 MAT CTRCT <SEQUENCE>9 <FILENAME>cns_a1-ex0604.htm <DESCRIPTION>EMPLOYMENT AGREEMENT BETWEEN CNS PHARMACEUTICALS, INC. AND JOHN M. CLIMACO <TEXT> Document 9 - file: cns_a1-ex0604.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX1A-6 MAT CTRCT <SEQUENCE>10 <FILENAME>cns_a1-ex0605.htm <DESCRIPTION>CONSULTING AGREEMENT <TEXT> Document 10 - file: cns_a1-ex0605.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX1A-11 CONSENT <SEQUENCE>11 <FILENAME>cns_a1-ex1101.htm <DESCRIPTION>CONSENT <TEXT> Document 11 - file: cns_a1-ex1101.htm
</DOCUMENT> </SEC-DOCUMENT>